Naloxone Administration for Opioid-Induced Respiratory Depression

Assessment and Immediate Management

• The American Heart Association recommends administering naloxone to patients with suspected opioid-induced respiratory depression, despite oxygen saturation levels, as the clinical presentation of respiratory distress is more important than the oxygen saturation number alone 1, 2, 3
• Patients on multiple narcotics are at high risk of opioid-induced respiratory depression, and naloxone administration is crucial in these cases 1, 2

Naloxone Administration and Monitoring

• The American Society of Anesthesiologists recommends observing patients for improvement in respiratory status and level of consciousness after naloxone administration, and being prepared for possible recurrence of respiratory depression as naloxone's duration of action may be shorter than that of many opioids 2, 3, 5, 6
• The American Heart Association suggests that naloxone can be administered via IV, IM, or subcutaneously, and that the dose may need to be repeated at 2-3 minute intervals if respiratory function does not improve 1, 2, 4

Post-Naloxone Management and Considerations

• The American Society of Anesthesiologists recommends continuing to monitor patients for at least 2 hours after naloxone administration, and considering longer observation periods for patients on long-acting opioids 5, 6
• The American Heart Association notes that naloxone may precipitate acute withdrawal syndrome in opioid-dependent patients, and that this risk can be minimized by using the lowest effective dose of naloxone 4